HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Avigan Selected Research

isocoumarin NM-3

2/2007A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Avigan Research Topics

Disease

41Neoplasms (Cancer)
07/2022 - 02/2003
30Multiple Myeloma
06/2022 - 04/2002
9Hematologic Neoplasms (Hematological Malignancy)
10/2021 - 05/2010
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 08/2006
7Leukemia
12/2022 - 08/2006
6Graft vs Host Disease (Graft-Versus-Host Disease)
12/2022 - 11/2015
6Lymphoma (Lymphomas)
01/2021 - 07/2007
4Breast Neoplasms (Breast Cancer)
01/2017 - 02/2003
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 01/2015
3Residual Neoplasm
10/2020 - 07/2013
3Necrosis
01/2017 - 06/2009
2Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2021 - 01/2017
2Myeloid Leukemia (Leukemia, Myelocytic)
11/2017 - 11/2016
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
10/2017 - 07/2015
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2010 - 12/2007
2Renal Cell Carcinoma (Grawitz Tumor)
07/2006 - 09/2004
1Injection Site Reaction
12/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2022
1Plasma Cell Neoplasms
04/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021
1Progressive Multifocal Leukoencephalopathy
10/2021
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2020
1Virus Diseases (Viral Diseases)
01/2020
1Peripheral Nervous System Diseases (PNS Diseases)
01/2019
1Hodgkin Disease (Hodgkin's Disease)
01/2019
1Lung Injury
01/2019
1Carcinogenesis
08/2018
1Heartburn (Pyrosis)
01/2017
1Lung Neoplasms (Lung Cancer)
01/2017
1Deglutition Disorders (Dysphagia)
01/2017

Drug/Important Bio-Agent (IBA)

17VaccinesIBA
12/2022 - 07/2004
15Cancer VaccinesIBA
07/2022 - 02/2003
14AntigensIBA
12/2021 - 05/2004
9Oncogene Proteins (Oncogene Protein)IBA
08/2018 - 12/2007
6Neoplasm Antigens (Tumor Antigens)IBA
07/2022 - 02/2003
5Chimeric Antigen ReceptorsIBA
06/2022 - 10/2020
5Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2004
5Mucin-1 (CA 15-3 Antigen)IBA
10/2017 - 06/2009
4Pharmaceutical PreparationsIBA
06/2022 - 10/2016
4Monoclonal AntibodiesIBA
10/2016 - 12/2013
3LigandsIBA
01/2019 - 01/2006
3Lenalidomide (CC 5013)FDA Link
01/2018 - 01/2013
3Peptides (Polypeptides)IBA
10/2014 - 09/2004
3CytokinesIBA
06/2012 - 08/2006
3Interleukin-12 (IL 12)IBA
07/2008 - 04/2002
2Tacrolimus (Prograf)FDA LinkGeneric
12/2022 - 01/2020
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2022 - 01/2011
2B-Cell Maturation AntigenIBA
06/2022 - 01/2021
2Proteasome InhibitorsIBA
06/2022 - 01/2021
2MicroRNAs (MicroRNA)IBA
01/2021 - 01/2019
2NivolumabIBA
11/2020 - 10/2016
2Sirolimus (Rapamycin)FDA Link
01/2020 - 04/2017
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2018 - 07/2012
2Immune Checkpoint InhibitorsIBA
01/2017 - 07/2016
2CateninsIBA
01/2017 - 11/2016
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2016 - 05/2011
2GO 201IBA
09/2010 - 06/2009
2bcr-abl Fusion ProteinsIBA
09/2010 - 12/2007
2Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
06/2005 - 07/2004
1Methotrexate (Mexate)FDA LinkGeneric
12/2022
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
12/2021
1OligonucleotidesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Single-Domain AntibodiesIBA
01/2021
1cobomarsenIBA
01/2021
1trans-crotonin (CTN)IBA
10/2020
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
1Dacarbazine (DIC)FDA LinkGeneric
01/2019
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2019
1AntibodiesIBA
01/2019
1Brentuximab VedotinIBA
01/2019
1Vinblastine (Vinblastine Sulfate)FDA Link
01/2019
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2018
1Etoposide (VP 16)FDA LinkGeneric
01/2018
1DecitabineFDA Link
10/2017
1Polycomb Repressive Complex 1IBA
09/2017
1Therapeutic UsesIBA
06/2017
1Proton Pump InhibitorsIBA
01/2017
1Cell-Penetrating PeptidesIBA
01/2017
1Programmed Cell Death 1 ReceptorIBA
01/2017
1(arginine)9- cysteinyl- glutaminyl- cysteinyl- arginyl- arginyl- lysyl- asparagineIBA
01/2017
1Interferon Regulatory FactorsIBA
01/2017
1Transcription Factors (Transcription Factor)IBA
01/2017
1Phosphotransferases (Kinase)IBA
11/2016
1tyrosine receptor (receptor, tyrosine)IBA
11/2016

Therapy/Procedure

28Therapeutics
07/2022 - 08/2006
13Immunotherapy
10/2021 - 02/2003
6Homologous Transplantation
11/2020 - 08/2006
5Drug Therapy (Chemotherapy)
07/2022 - 11/2015
4Stem Cell Transplantation
01/2016 - 07/2006
3Cell Transplantation
11/2020 - 04/2017
3Hematopoietic Stem Cell Transplantation
07/2016 - 03/2005
2Transplantation
01/2020 - 05/2016
1Intravenous Injections
01/2021
1Intravenous Administration
01/2021
1Drug Tapering
01/2019
1Immunomodulation
01/2018
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2017
1Aftercare (After-Treatment)
01/2017